Logo image of KIN.BR

KINEPOLIS (KIN.BR) Stock Fundamental Analysis

Europe - Euronext Brussels - EBR:KIN - BE0974274061 - Common Stock

29.55 EUR
-0.35 (-1.17%)
Last: 12/10/2025, 7:00:00 PM
Fundamental Rating

4

Taking everything into account, KIN scores 4 out of 10 in our fundamental rating. KIN was compared to 48 industry peers in the Entertainment industry. There are concerns on the financial health of KIN while its profitability can be described as average. KIN scores decently on growth, while it is valued quite cheap. This could make an interesting combination.


Dividend Valuation Growth Profitability Health

5

1. Profitability

1.1 Basic Checks

KIN had positive earnings in the past year.
In the past year KIN had a positive cash flow from operations.
In multiple years KIN reported negative net income over the last 5 years.
KIN had a positive operating cash flow in 4 of the past 5 years.
KIN.BR Yearly Net Income VS EBIT VS OCF VS FCFKIN.BR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M -50M 100M 150M

1.2 Ratios

The Return On Assets of KIN (4.54%) is better than 68.75% of its industry peers.
With an excellent Return On Equity value of 23.61%, KIN belongs to the best of the industry, outperforming 83.33% of the companies in the same industry.
KIN has a better Return On Invested Capital (8.28%) than 72.92% of its industry peers.
KIN had an Average Return On Invested Capital over the past 3 years of 6.76%. This is below the industry average of 10.43%.
The 3 year average ROIC (6.76%) for KIN is below the current ROIC(8.28%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 4.54%
ROE 23.61%
ROIC 8.28%
ROA(3y)3.57%
ROA(5y)0.53%
ROE(3y)21.42%
ROE(5y)-2.24%
ROIC(3y)6.76%
ROIC(5y)N/A
KIN.BR Yearly ROA, ROE, ROICKIN.BR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 -40

1.3 Margins

KIN has a Profit Margin of 7.98%. This is in the better half of the industry: KIN outperforms 70.83% of its industry peers.
In the last couple of years the Profit Margin of KIN has declined.
KIN has a better Operating Margin (15.19%) than 89.58% of its industry peers.
In the last couple of years the Operating Margin of KIN has declined.
With a Gross Margin value of 24.54%, KIN is not doing good in the industry: 87.50% of the companies in the same industry are doing better.
In the last couple of years the Gross Margin of KIN has declined.
Industry RankSector Rank
OM 15.19%
PM (TTM) 7.98%
GM 24.54%
OM growth 3YN/A
OM growth 5Y-4.79%
PM growth 3YN/A
PM growth 5Y-6.62%
GM growth 3Y115.73%
GM growth 5Y-3.42%
KIN.BR Yearly Profit, Operating, Gross MarginsKIN.BR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 -40

2

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), KIN is creating some value.
Compared to 1 year ago, KIN has about the same amount of shares outstanding.
KIN has more shares outstanding than it did 5 years ago.
The debt/assets ratio for KIN has been reduced compared to a year ago.
KIN.BR Yearly Shares OutstandingKIN.BR Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M 25M
KIN.BR Yearly Total Debt VS Total AssetsKIN.BR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

2.2 Solvency

Based on the Altman-Z score of 1.54, we must say that KIN is in the distress zone and has some risk of bankruptcy.
The Altman-Z score of KIN (1.54) is better than 60.42% of its industry peers.
KIN has a debt to FCF ratio of 5.38. This is a neutral value as KIN would need 5.38 years to pay back of all of its debts.
KIN's Debt to FCF ratio of 5.38 is in line compared to the rest of the industry. KIN outperforms 47.92% of its industry peers.
KIN has a Debt/Equity ratio of 2.87. This is a high value indicating a heavy dependency on external financing.
KIN has a Debt to Equity ratio of 2.87. This is in the lower half of the industry: KIN underperforms 70.83% of its industry peers.
Industry RankSector Rank
Debt/Equity 2.87
Debt/FCF 5.38
Altman-Z 1.54
ROIC/WACC1.48
WACC5.6%
KIN.BR Yearly LT Debt VS Equity VS FCFKIN.BR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M 600M 800M

2.3 Liquidity

A Current Ratio of 0.47 indicates that KIN may have some problems paying its short term obligations.
With a Current ratio value of 0.47, KIN is not doing good in the industry: 89.58% of the companies in the same industry are doing better.
A Quick Ratio of 0.44 indicates that KIN may have some problems paying its short term obligations.
Looking at the Quick ratio, with a value of 0.44, KIN is doing worse than 89.58% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 0.47
Quick Ratio 0.44
KIN.BR Yearly Current Assets VS Current LiabilitesKIN.BR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M 250M

5

3. Growth

3.1 Past

KIN shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 34.32%, which is quite impressive.
The Earnings Per Share has been decreasing by -5.80% on average over the past years.
KIN shows a small growth in Revenue. In the last year, the Revenue has grown by 5.38%.
KIN shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 0.95% yearly.
EPS 1Y (TTM)34.32%
EPS 3YN/A
EPS 5Y-5.8%
EPS Q2Q%5581.82%
Revenue 1Y (TTM)5.38%
Revenue growth 3Y29.47%
Revenue growth 5Y0.95%
Sales Q2Q%6.22%

3.2 Future

KIN is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 14.94% yearly.
The Revenue is expected to grow by 4.98% on average over the next years.
EPS Next Y22.89%
EPS Next 2Y26.59%
EPS Next 3Y21.24%
EPS Next 5Y14.94%
Revenue Next Year3.49%
Revenue Next 2Y9.56%
Revenue Next 3Y7.85%
Revenue Next 5Y4.98%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
KIN.BR Yearly Revenue VS EstimatesKIN.BR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 200M 400M 600M 800M
KIN.BR Yearly EPS VS EstimatesKIN.BR Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 0 1 -1 2 -2

7

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 17.28 indicates a rather expensive valuation of KIN.
Compared to the rest of the industry, the Price/Earnings ratio of KIN indicates a rather cheap valuation: KIN is cheaper than 85.42% of the companies listed in the same industry.
KIN's Price/Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 26.59.
Based on the Price/Forward Earnings ratio of 11.00, the valuation of KIN can be described as reasonable.
Compared to the rest of the industry, the Price/Forward Earnings ratio of KIN indicates a rather cheap valuation: KIN is cheaper than 83.33% of the companies listed in the same industry.
The average S&P500 Price/Forward Earnings ratio is at 23.80. KIN is valued rather cheaply when compared to this.
Industry RankSector Rank
PE 17.28
Fwd PE 11
KIN.BR Price Earnings VS Forward Price EarningsKIN.BR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of KIN indicates a somewhat cheap valuation: KIN is cheaper than 68.75% of the companies listed in the same industry.
KIN's Price/Free Cash Flow ratio is rather cheap when compared to the industry. KIN is cheaper than 83.33% of the companies in the same industry.
Industry RankSector Rank
P/FCF 6.19
EV/EBITDA 8.49
KIN.BR Per share dataKIN.BR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15 20

4.3 Compensation for Growth

KIN's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as KIN's earnings are expected to grow with 21.24% in the coming years.
PEG (NY)0.75
PEG (5Y)N/A
EPS Next 2Y26.59%
EPS Next 3Y21.24%

3

5. Dividend

5.1 Amount

KIN has a Yearly Dividend Yield of 1.25%.
Compared to an average industry Dividend Yield of 2.26, KIN pays a bit more dividend than its industry peers.
Compared to an average S&P500 Dividend Yield of 2.31, KIN's dividend is way lower than the S&P500 average.
Industry RankSector Rank
Dividend Yield 1.25%

5.2 History

The dividend of KIN decreases each year by -3.32%.
Dividend Growth(5Y)-3.32%
Div Incr Years1
Div Non Decr Years2
KIN.BR Yearly Dividends per shareKIN.BR Yearly Dividends per shareYearly Dividends per share 2019 2020 2023 2024 2025 0.2 0.4 0.6 0.8

5.3 Sustainability

31.09% of the earnings are spent on dividend by KIN. This is a low number and sustainable payout ratio.
DP31.09%
EPS Next 2Y26.59%
EPS Next 3Y21.24%
KIN.BR Yearly Income VS Free CF VS DividendKIN.BR Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M -50M 100M
KIN.BR Dividend Payout.KIN.BR Dividend Payout, showing the Payout Ratio.KIN.BR Dividend Payout.PayoutRetained Earnings

KINEPOLIS

EBR:KIN (12/10/2025, 7:00:00 PM)

29.55

-0.35 (-1.17%)

Chartmill FA Rating
GICS IndustryGroupMedia & Entertainment
GICS IndustryEntertainment
Earnings (Last)08-21 2025-08-21
Earnings (Next)02-20 2026-02-20/amc
Inst Owners17.66%
Inst Owner ChangeN/A
Ins Owners1.8%
Ins Owner ChangeN/A
Market Cap808.78M
Revenue(TTM)593.29M
Net Income(TTM)47.32M
Analysts86
Price Target49.3 (66.84%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 1.25%
Yearly Dividend0.54
Dividend Growth(5Y)-3.32%
DP31.09%
Div Incr Years1
Div Non Decr Years2
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0.35%
PT rev (3m)-0.55%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)-3.13%
EPS NY rev (3m)-10.6%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0.12%
Revenue NY rev (3m)-2.18%
Valuation
Industry RankSector Rank
PE 17.28
Fwd PE 11
P/S 1.36
P/FCF 6.19
P/OCF 4.66
P/B 4.04
P/tB 36.09
EV/EBITDA 8.49
EPS(TTM)1.71
EY5.79%
EPS(NY)2.69
Fwd EY9.09%
FCF(TTM)4.77
FCFY16.15%
OCF(TTM)6.34
OCFY21.45%
SpS21.68
BVpS7.32
TBVpS0.82
PEG (NY)0.75
PEG (5Y)N/A
Graham Number16.79
Profitability
Industry RankSector Rank
ROA 4.54%
ROE 23.61%
ROCE 11.27%
ROIC 8.28%
ROICexc 8.93%
ROICexgc 11.76%
OM 15.19%
PM (TTM) 7.98%
GM 24.54%
FCFM 22.02%
ROA(3y)3.57%
ROA(5y)0.53%
ROE(3y)21.42%
ROE(5y)-2.24%
ROIC(3y)6.76%
ROIC(5y)N/A
ROICexc(3y)7.02%
ROICexc(5y)N/A
ROICexgc(3y)8.91%
ROICexgc(5y)N/A
ROCE(3y)9.19%
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5Y-1%
ROICexc growth 3YN/A
ROICexc growth 5Y-1.69%
OM growth 3YN/A
OM growth 5Y-4.79%
PM growth 3YN/A
PM growth 5Y-6.62%
GM growth 3Y115.73%
GM growth 5Y-3.42%
F-Score8
Asset Turnover0.57
Health
Industry RankSector Rank
Debt/Equity 2.87
Debt/FCF 5.38
Debt/EBITDA 3.35
Cap/Depr 52.23%
Cap/Sales 7.23%
Interest Coverage 4.1
Cash Conversion 100.75%
Profit Quality 276.05%
Current Ratio 0.47
Quick Ratio 0.44
Altman-Z 1.54
F-Score8
WACC5.6%
ROIC/WACC1.48
Cap/Depr(3y)43.12%
Cap/Depr(5y)41.32%
Cap/Sales(3y)6.29%
Cap/Sales(5y)10.19%
Profit Quality(3y)301.12%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)34.32%
EPS 3YN/A
EPS 5Y-5.8%
EPS Q2Q%5581.82%
EPS Next Y22.89%
EPS Next 2Y26.59%
EPS Next 3Y21.24%
EPS Next 5Y14.94%
Revenue 1Y (TTM)5.38%
Revenue growth 3Y29.47%
Revenue growth 5Y0.95%
Sales Q2Q%6.22%
Revenue Next Year3.49%
Revenue Next 2Y9.56%
Revenue Next 3Y7.85%
Revenue Next 5Y4.98%
EBIT growth 1Y16.5%
EBIT growth 3YN/A
EBIT growth 5Y-3.89%
EBIT Next Year104.02%
EBIT Next 3Y35.57%
EBIT Next 5Y22.36%
FCF growth 1Y30.27%
FCF growth 3Y19%
FCF growth 5Y6.53%
OCF growth 1Y26.43%
OCF growth 3Y22.57%
OCF growth 5Y1.63%

KINEPOLIS / KIN.BR FAQ

Can you provide the ChartMill fundamental rating for KINEPOLIS?

ChartMill assigns a fundamental rating of 4 / 10 to KIN.BR.


What is the valuation status of KINEPOLIS (KIN.BR) stock?

ChartMill assigns a valuation rating of 7 / 10 to KINEPOLIS (KIN.BR). This can be considered as Undervalued.


What is the profitability of KIN stock?

KINEPOLIS (KIN.BR) has a profitability rating of 5 / 10.


What is the earnings growth outlook for KINEPOLIS?

The Earnings per Share (EPS) of KINEPOLIS (KIN.BR) is expected to grow by 22.89% in the next year.


Can you provide the dividend sustainability for KIN stock?

The dividend rating of KINEPOLIS (KIN.BR) is 3 / 10 and the dividend payout ratio is 31.09%.